Try our beta test site
90 studies found for:    heart block | Open Studies | NIH, U.S. Fed
Show Display Options
Rank Status Study
21 Not yet recruiting Pathophysiology of Acute Pain in Patients With Sickle Cell Disease
Condition: Sickle Cell Disease
Intervention:
22 Recruiting Cardiometabolic Effects of Eplerenone in HIV Infection
Conditions: Cardiac Steatosis;   Hepatic Steatosis
Intervention: Drug: Inspra /Eplerenone
23 Recruiting Liposomal Bupivacaine for Pain Control After Total Shoulder Arthroplasty
Conditions: Osteoarthritis;   Arthropathy;   Shoulder Pain;   Closed Fracture Proximal Humerus, Four Part
Interventions: Drug: Liposomal bupivacaine;   Drug: Interscalene Nerve Block
24 Recruiting Randomized Endo-Vein Graft Prospective
Condition: Coronary Artery Bypass Grafting
Intervention: Procedure: Vein Harvesting Procedures
25 Recruiting Nebulized or Inhaled Albuterol for Lymphangioleiomyomatosis
Condition: Lymphangioleiomyomatosis
Interventions: Drug: albuterol inhaler;   Procedure: PFT;   Drug: albuterol nebulizer
26 Recruiting Randomized Controlled Trial of Group Prevention Coaching
Condition: Cardiovascular Disease
Intervention: Behavioral: Problem Solving
27 Recruiting Prospective Evaluation of Next Generation CT Reconstruction (NextGenIR)
Condition: Healthy Subjects
Intervention:
28 Recruiting Longitudinal Observational Study of Severe Asthma
Condition: Asthma
Intervention:
29 Recruiting Clinical and Basic Investigations Into Known and Suspected Congenital Disorders of Glycosylation
Condition: Congenital Disorders of Glycosylation
Intervention:
30 Not yet recruiting Effects of SRX246, a Vasopressin Receptor (V1a) Antagonist, on an Experimental Model of Fear and Anxiety in Humans
Conditions: Anxiety Disorder;   Fear
Interventions: Drug: SRX246;   Drug: Placebo
31 Not yet recruiting Insulin-like Growth Factor 1 Receptor (IGF-1R) Antibody AMG479 (Ganitumab) in Combination With the Src Family Kinase (SFK) Inhibitor Dasatinib in People With Embryonal and Alveolar Rhabdomyosarcoma
Conditions: Rhabdomyosarcoma;   Rhabdomyosarcoma- Alveolar;   Rhabdomyosarcoma-Embryonal
Interventions: Drug: Dasatinib;   Drug: Ganitumab
32 Recruiting A Phase II Single Arm Pilot Study of the Chk1/2 Inhibitor (LY2606368) in BRCA1/2 Mutation Associated Breast or Ovarian Cancer, Triple Negative Breast Cancer, High Grade Serous Ovarian Cancer, and Metastatic Castrate-Resistant Prostate Cancer
Conditions: Ovarian Cancer;   Breast Cancer;   Prostate Cancer
Intervention: Drug: LY2606368
33 Recruiting Phase II Study of Cediranib (AZD2171) in Patients With Alveolar Soft Part Sarcoma
Condition: Sarcoma, Alveolar Soft Part
Intervention: Drug: AZD2171
34 Recruiting Combination Nilotinib and Paclitaxel in Adults With Relapsed Solid Tumors
Condition: Solid Tumors
Intervention: Drug: Nilotinib + Paclitaxel
35 Recruiting Bisnorcymserine in Healthy Adult Volunteers
Condition: Alzheimer's Disease
Intervention: Drug: BNC
36 Recruiting A Novel Compound for Alcoholism Treatment: A Translational Strategy
Condition: Alcoholism
Interventions: Drug: PF-05190457;   Behavioral: MI-VF;   Other: Placebo;   Other: Counseling
37 Not yet recruiting Deep Brain Stimulation Surgery for Focal Hand Dystonia
Conditions: Dystonia;   Focal Dystonia;   Musician's Dystonia
Intervention: Procedure: DBS surgery
38 Recruiting Study of Alkaptonuria
Condition: Alkaptonuria
Intervention:
39 Recruiting Mifepristone for Metabolic Syndrome
Conditions: Endocrine Disease;   Diabetes
Intervention: Drug: Mifepristone
40 Recruiting Plerixafor After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed High Grade Glioma
Conditions: Adult Ependymoblastoma;   Adult Giant Cell Glioblastoma;   Adult Glioblastoma;   Adult Gliosarcoma;   Adult Medulloblastoma;   Adult Mixed Glioma;   Adult Oligodendroglial Tumors;   Adult Pineoblastoma;   Adult Supratentorial Primitive Neuroectodermal Tumor (PNET)
Interventions: Radiation: radiation therapy;   Drug: temozolomide;   Drug: plerixafor;   Other: laboratory biomarker analysis;   Other: pharmacological study

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.